Bottom line
SHISX vs SCHLX: the short answer
SHISX (Blackrock Health Sciences Opportunities Portfolio) and SCHLX (DWS Health and Wellness Fund) are both mutual funds.
But SHISX is far broader, holding 155 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
SCHLX is cheaper at 1.06% vs 1.16% — a difference of $10.00 a year per $10,000 invested.
Updated Nov 19, 2026
SHISX vs SCHLX side by side
| SHISX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.16% | 1.06% |
| Annual cost per $10k | $116 | $106 |
| 10-yr cost on $10k (prospectus) | $1,409 | $1,294 |
| Max front load | — | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +15.9% | — |
| 5-yr return (annualized) | +5.5% | — |
| 10-yr return (annualized) | +9.5% | — |
| Best quarter | +17.5% | — |
| Worst quarter | −11.5% | — |
| Net assets (fund) | $5.9B | $231.8M |
| Number of holdings | 155 | 65 |
| Portfolio turnover | 49% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of SHISX's top 25 holdings also appear in SCHLX's top 25.
| Holding | SHISX | SCHLX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 13.85% |
| Johnson & Johnson | 8.77% | 6.19% |
| Unitedhealth Group Inc | 6.10% | 5.73% |
| Merck & Company Inc | 4.94% | 4.85% |
| Gilead Sciences Inc | 4.19% | 2.78% |
| Abbvie Inc | 3.94% | 4.90% |
| Amgen Inc | 3.37% | 2.88% |
| Thermo Fisher Scientific Inc | 3.02% | 3.46% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.45% |
| Pfizer Inc | 2.61% | 1.17% |
| Danaher Corp | 2.00% | 2.13% |
| Abbott Laboratories | 1.97% | 2.39% |
| Intuitive Surgical Inc | 1.95% | 2.69% |
| Boston Scientific Corp | 1.59% | 2.10% |
| Astrazeneca Plc | 1.21% | 3.80% |
Source: SEC Form N-PORT
SHISX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between SHISX and SCHLX?
Which is cheaper, SHISX or SCHLX?
Should I own both SHISX and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.